U.S. federal trademark · Serial No. 88186213
Medical apparatus and instrument for analyzing disease and genome information, namely, an enrichment-based diagnostic NGS (Next Generation Sequencing) testing panel assay used for extracting and sequencing nucleic acid, DNA, RNA from cancer cells to detect mutations therein and provide information about such mutations, all for the purpose of planning medical treatments for and providing targeted therapy selection to cancer patients
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.